{"first_name":"DR.","last_name":"MARION JUNG","permalink":"dr-marion-jung","crunchbase_url":"http://www.crunchbase.com/person/dr-marion-jung","homepage_url":null,"birthplace":null,"twitter_username":null,"blog_url":null,"blog_feed_url":null,"affiliation_name":"Earlybird Venture Capital","born_year":null,"born_month":null,"born_day":null,"tag_list":"","alias_list":null,"created_at":"Thu Dec 04 09:43:35 UTC 2008","updated_at":"Mon Jul 18 20:18:07 UTC 2011","overview":"<p>Principal of Earlybird</p>\n\n<p>More than 13 years experience as investor; focus on medical technology, pharmaceutical industry, cleantech \nServes as reviewer for KMU-innovativ grants, provided by the Federal Ministry of Education and Research for SME companies</p>\n\n<p>Shared responsibility for Amaxa (to Lonza, SWX: LONN), Wilex (IPO Prime Standard FSE: WL6), Dianoema (IPO Milan: NOE.MI)</p>\n\n<p>Postdoctorate at Chair for Molecular Biology, Ludwig Maximilian University, Munich \nResearch at Arizona State University and Marine Biological Laboratory, Massachusetts \nDipl.-Biol. (MS equivalent) and PhD, Ludwig Maximilian University, Munich</p>","image":{"available_sizes":[[[150,139],"assets/images/resized/0014/4730/144730v2-max-150x150.jpg"],[[250,233],"assets/images/resized/0014/4730/144730v2-max-250x250.jpg"],[[295,275],"assets/images/resized/0014/4730/144730v2-max-450x450.jpg"]],"attribution":""},"degrees":[],"relationships":[{"is_past":true,"title":"Principal","firm":{"name":"Earlybird Venture Capital","permalink":"earlybird-venture-capital","type_of_entity":"financial_org","image":{"available_sizes":[[[150,15],"assets/images/resized/0003/1016/31016v7-max-150x150.jpg"],[[250,25],"assets/images/resized/0003/1016/31016v7-max-250x250.jpg"],[[280,28],"assets/images/resized/0003/1016/31016v7-max-450x450.jpg"]],"attribution":null}}}],"investments":[],"milestones":[],"video_embeds":[],"external_links":[],"web_presences":[]}